Strengthening Oncology Data Systems for Equitable Care in Asia-Pacific: Current Practices and Future Directions

IF 2.5 3区 医学 Q2 ONCOLOGY
Clinical oncology Pub Date : 2026-03-01 Epub Date: 2026-01-21 DOI:10.1016/j.clon.2026.104051
V. Batumalai , M. Zhou , M. Chilkuri , S. Costello , D. Fraser , S. Ghosh-Laskar , Handoko , A. Liao , A. Teyateeti , G. Xiong , M.L. Yap
{"title":"Strengthening Oncology Data Systems for Equitable Care in Asia-Pacific: Current Practices and Future Directions","authors":"V. Batumalai ,&nbsp;M. Zhou ,&nbsp;M. Chilkuri ,&nbsp;S. Costello ,&nbsp;D. Fraser ,&nbsp;S. Ghosh-Laskar ,&nbsp;Handoko ,&nbsp;A. Liao ,&nbsp;A. Teyateeti ,&nbsp;G. Xiong ,&nbsp;M.L. Yap","doi":"10.1016/j.clon.2026.104051","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>Effective oncology data management through oncology information systems (OIS) is essential for high-quality cancer care, yet adoption across the Asia-Pacific (APAC) region varies widely. This study benchmarked OIS utilisation, data capture, and integration across APAC to identify gaps and inform targeted improvements.</div></div><div><h3>Materials and methods</h3><div>A regional survey was distributed to radiotherapy professionals in 19 APAC countries. The questionnaire assessed OIS utilisation, data capture, IT support, training, and system integration. Responses were analysed descriptively and stratified by World Bank income group: low-middle-income countries (L-MIC), upper-middle-income countries (U-MIC), and high-income countries (HIC).</div></div><div><h3>Results</h3><div>A total of 149 responses were analysed. OIS functionality was limited in L-MICs and U-MICs, with only 34% and 59% of centres, respectively, using OIS beyond basic record-and-verify functions. Basic demographic data such as date of birth (83% L-MIC, 90% U-MIC) and sex at birth (98% L-MIC, 91% U-MIC) were consistently captured, but equity-related data were poorly documented (ethnicity 48% U-MIC, 59% HIC; disadvantaged group status rarely recorded in 78% of L-MICs). Radiotherapy data including treatment site (84% to 98%), intent (77% to 90%), and modality (86% to 95%) were consistently documented. However, the location of data capture varied: radiotherapy data were more frequently entered into OIS structured fields (35% L-MIC/U-MIC, 50% HIC), while demographic and diagnosis data showed lower structured capture in OIS (18% to 24% in L-MICs). Reliance on paper records remained widespread in L-MICs and U-MICs.</div></div><div><h3>Conclusion</h3><div>Marked disparities in OIS utilisation and data quality exist across APAC. Regional strategies should prioritise comprehensive training and standardised datasets to improve cancer care quality and equity.</div></div>","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"51 ","pages":"Article 104051"},"PeriodicalIF":2.5000,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical oncology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0936655526000221","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/21 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aims

Effective oncology data management through oncology information systems (OIS) is essential for high-quality cancer care, yet adoption across the Asia-Pacific (APAC) region varies widely. This study benchmarked OIS utilisation, data capture, and integration across APAC to identify gaps and inform targeted improvements.

Materials and methods

A regional survey was distributed to radiotherapy professionals in 19 APAC countries. The questionnaire assessed OIS utilisation, data capture, IT support, training, and system integration. Responses were analysed descriptively and stratified by World Bank income group: low-middle-income countries (L-MIC), upper-middle-income countries (U-MIC), and high-income countries (HIC).

Results

A total of 149 responses were analysed. OIS functionality was limited in L-MICs and U-MICs, with only 34% and 59% of centres, respectively, using OIS beyond basic record-and-verify functions. Basic demographic data such as date of birth (83% L-MIC, 90% U-MIC) and sex at birth (98% L-MIC, 91% U-MIC) were consistently captured, but equity-related data were poorly documented (ethnicity 48% U-MIC, 59% HIC; disadvantaged group status rarely recorded in 78% of L-MICs). Radiotherapy data including treatment site (84% to 98%), intent (77% to 90%), and modality (86% to 95%) were consistently documented. However, the location of data capture varied: radiotherapy data were more frequently entered into OIS structured fields (35% L-MIC/U-MIC, 50% HIC), while demographic and diagnosis data showed lower structured capture in OIS (18% to 24% in L-MICs). Reliance on paper records remained widespread in L-MICs and U-MICs.

Conclusion

Marked disparities in OIS utilisation and data quality exist across APAC. Regional strategies should prioritise comprehensive training and standardised datasets to improve cancer care quality and equity.
加强肿瘤学数据系统在亚太地区的公平护理:目前的做法和未来的方向。
目的:通过肿瘤信息系统(OIS)进行有效的肿瘤数据管理对于高质量的癌症治疗至关重要,但亚太地区(APAC)的采用差异很大。本研究对整个亚太地区的OIS利用率、数据捕获和集成进行了基准测试,以确定差距并告知有针对性的改进。材料和方法:对亚太地区19个国家的放射治疗专业人员进行了区域调查。问卷评估了OIS的使用、数据采集、IT支持、培训和系统集成。对反馈进行了描述性分析,并按世界银行收入组进行了分层:中低收入国家(L-MIC)、中高收入国家(U-MIC)和高收入国家(HIC)。结果:共对149份问卷进行分析。OIS功能在l - mic和u - mic中受到限制,分别只有34%和59%的中心在基本的记录和验证功能之外使用OIS。基本的人口统计数据,如出生日期(83%的L-MIC, 90%的U-MIC)和出生性别(98%的L-MIC, 91%的U-MIC)得到了一致的记录,但与公平相关的数据记录很少(种族48%的U-MIC, 59%的HIC; 78%的L-MIC很少记录弱势群体的地位)。放疗数据包括治疗部位(84%至98%)、意图(77%至90%)和方式(86%至95%)均被一致记录。然而,数据捕获的位置各不相同:放疗数据更频繁地进入OIS结构化领域(35% L-MIC/U-MIC, 50% HIC),而人口统计学和诊断数据显示OIS的结构化捕获较低(L-MIC为18%至24%)。在l - mic和u - mic中,对纸质记录的依赖仍然很普遍。结论:亚太地区在OIS利用和数据质量方面存在显著差异。区域战略应优先考虑全面培训和标准化数据集,以提高癌症护理的质量和公平性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical oncology
Clinical oncology 医学-肿瘤学
CiteScore
5.20
自引率
8.80%
发文量
332
审稿时长
40 days
期刊介绍: Clinical Oncology is an International cancer journal covering all aspects of the clinical management of cancer patients, reflecting a multidisciplinary approach to therapy. Papers, editorials and reviews are published on all types of malignant disease embracing, pathology, diagnosis and treatment, including radiotherapy, chemotherapy, surgery, combined modality treatment and palliative care. Research and review papers covering epidemiology, radiobiology, radiation physics, tumour biology, and immunology are also published, together with letters to the editor, case reports and book reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书